Logo

New Products: Agilent Technologies' SurePrint G3 Human Gene-Expression Microarray

May 22, 2012
Premium

Agilent Technologies this week launched the second version of its SurePrint G3 Human Gene-Expression Microarray.

The updated chip includes probes designed using the Broad Institute's human reference catalog of large intergenic noncoding RNAs. It also includes the latest mRNA content from the National Center for Biotechnology Information's RefSeq gene database.

LincRNAs are believed to be "important" regulators of gene expression, playing a role in embryonic development and other cellular processes, Agilent said. The firm will allow users to design custom chips by selecting lincRNA and other mRNA content that is relevant to their experiments.

Filed under

Microarrays & Multiplexing
microarrays
Agilent
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.